{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T05:19:47Z","timestamp":1792905587755,"version":"4.5.0"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004607","name":"Natural Science Foundation of Guangxi Province","doi-asserted-by":"publisher","award":["2018JJB140325"],"award-info":[{"award-number":["2018JJB140325"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004607","name":"Natural Science Foundation of Guangxi Province","doi-asserted-by":"publisher","award":["2018JJB140377"],"award-info":[{"award-number":["2018JJB140377"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007620","name":"Department of Education of Liaoning Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007620","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013099","name":"Scientific Research Fund of Liaoning Provincial Education Department","doi-asserted-by":"publisher","award":["2019LCJ08"],"award-info":[{"award-number":["2019LCJ08"]}],"id":[{"id":"10.13039\/501100013099","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ejphar.2021.174291","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:02:45Z","timestamp":1625097765000},"page":"174291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"special_numbering":"C","title":["A brief review of urate transporter 1 (URAT1) inhibitors for the treatment of hyperuricemia and gout: Current therapeutic options and potential applications"],"prefix":"10.1016","volume":"907","author":[{"given":"Danni","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8537-1414","authenticated-orcid":false,"given":"Xu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2021.174291_bib1","article-title":"SAT0356\u2005The therapeutic efficacy of the novel uricosuric agent UR-1102 for hyperuricemia and gout","volume":"72","author":"Ahn","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejphar.2021.174291_bib2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1124\/jpet.115.231647","article-title":"Stronger uricosuric effects of the novel selective URAT1 inhibitor UR-1102 lowered plasma urate in tufted Capuchin monkeys to a greater extent than benzbromarone","volume":"357","author":"Ahn","year":"2016","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2021.174291_bib3","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1208\/s12248-014-9709-1","article-title":"Population pharmacokinetics and exposure-uric acid analyses after single and multiple doses of ABT-639, a calcium channel blocker, in healthy volunteers","volume":"17","author":"An","year":"2015","journal-title":"AAPS J."},{"key":"10.1016\/j.ejphar.2021.174291_bib4","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.3389\/fphar.2019.01464","article-title":"Effect of Eurycoma longifolia stem extract on uric acid excretion in hyperuricemia mice","volume":"10","author":"Bao","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174291_bib5","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1136\/annrheumdis-2016-209213","article-title":"Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study)","volume":"76","author":"Bardin","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejphar.2021.174291_bib6","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fmed.2018.00160","article-title":"Physiology of hyperuricemia and urate-lowering treatments","volume":"5","author":"Benn","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ejphar.2021.174291_bib7","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.amjmed.2010.03.027","article-title":"Serum uric acid levels and the risk of type 2 diabetes: a prospective study","volume":"123","author":"Bhole","year":"2010","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejphar.2021.174291_bib8","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1097\/HJH.0000000000000701","article-title":"Serum uric acid and the risk of cardiovascular and renal disease","volume":"33","author":"Borghi","year":"2015","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ejphar.2021.174291_bib9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.7748\/ns.29.2.50.e8464","article-title":"Gout: clinical presentation and management","volume":"29","author":"Burbage","year":"2014","journal-title":"Nurs. Stand."},{"key":"10.1016\/j.ejphar.2021.174291_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23020252","article-title":"Systematic structure-activity relationship (SAR) exploration of diarylmethane backbone and discovery of A highly potent novel uric acid transporter 1 (URAT1) inhibitor","volume":"23","author":"Cai","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2021.174291_bib11","first-page":"897","article-title":"A systematic review of uric acid transporter 1 (URAT1) inhibitors for the treatment of hyperuricemia and gout and an insight into the structure-activity relationship (SAR)","volume":"36","author":"Cai","year":"2017","journal-title":"Chin. J. Struct. Chem."},{"key":"10.1016\/j.ejphar.2021.174291_bib12","doi-asserted-by":"crossref","first-page":"499","DOI":"10.7326\/0003-4819-143-7-200510040-00009","article-title":"Pathogenesis of gout","volume":"143","author":"Choi","year":"2005","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejphar.2021.174291_bib13","doi-asserted-by":"crossref","DOI":"10.4172\/jtco.1000104","article-title":"Theoretical study of uric acid and its ions in aqueous solution","volume":"1","author":"Chong","year":"2013","journal-title":"J. Theor. Comput. Sci."},{"key":"10.1016\/j.ejphar.2021.174291_bib14","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/S0140-6736(16)00346-9","article-title":"Gout","volume":"388","author":"Dalbeth","year":"2016","journal-title":"The Lancet."},{"key":"10.1016\/j.ejphar.2021.174291_bib15","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1002\/art.40159","article-title":"Lesinurad, a selective uric acid reabsorption inhibitor, in combination with febuxostat in patients with tophaceous gout: findings of a phase III clinical trial","volume":"69","author":"Dalbeth","year":"2017","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2021.174291_bib16","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1136\/annrheumdis-2017-212288","article-title":"Relationship between serum urate concentration and clinically evident incident gout: an individual participant data analysis","volume":"77","author":"Dalbeth","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejphar.2021.174291_bib17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13075-018-1788-4","article-title":"Efficacy and safety during extended treatment of lesinurad in combination with febuxostat in patients with tophaceous gout: CRYSTAL extension study","volume":"21","author":"Dalbeth","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ejphar.2021.174291_bib18","first-page":"145","article-title":"New and improved strategies for the treatment of gout","volume":"3","author":"Dubchak","year":"2010","journal-title":"Int. J. Nephrol. Renovascular Dis."},{"key":"10.1016\/j.ejphar.2021.174291_bib19","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nature742","article-title":"Molecular identification of a renal urate anion exchanger that regulates blood urate levels","volume":"417","author":"Enomoto","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2021.174291_bib20","article-title":"Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with febuxostat in adults with gout: a phase IIa, open-label study","volume":"4","author":"Fleischmann","year":"2018","journal-title":"RMD Open"},{"key":"10.1016\/j.ejphar.2021.174291_bib21","article-title":"Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with allopurinol in adults with gout: a phase IIa, open-label study","volume":"4","author":"Fleischmann","year":"2018","journal-title":"RMD Open"},{"key":"10.1016\/j.ejphar.2021.174291_bib22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10157-019-01825-3","article-title":"Effects of mild and moderate renal dysfunction on pharmacokinetics, pharmacodynamics, and safety of dotinurad: a novel selective urate reabsorption inhibitor","volume":"24","author":"Fukase","year":"2020","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.ejphar.2021.174291_bib23","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s10157-020-01855-2","article-title":"A drug-drug interaction study of a novel, selective urate reabsorption inhibitor dotinurad and the non-steroidal anti-inflammatory drug oxaprozin in healthy adult males","volume":"24","author":"Furihata","year":"2020","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.ejphar.2021.174291_bib24","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.2147\/DDDT.S119944","article-title":"Effects of renal function on pharmacokinetics and pharmacodynamics of lesinurad in adult volunteers","volume":"10","author":"Gillen","year":"2016","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejphar.2021.174291_bib25","doi-asserted-by":"crossref","first-page":"2968135","DOI":"10.1155\/2020\/2968135","article-title":"Hypouricemic effects of extracts from urtica hyperborea Jacq. Ex Wedd. in hyperuricemia mice through XOD, URAT1, and OAT1","volume":"2020","author":"Han","year":"2020","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ejphar.2021.174291_bib26","doi-asserted-by":"crossref","first-page":"7390504","DOI":"10.1155\/2016\/7390504","article-title":"Natural products improving hyperuricemia with hepatorenal dual effects","author":"Hao","year":"2016","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.ejphar.2021.174291_bib27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1385\/CBB:32:1-3:123","article-title":"Evolution of urate-degrading enzymes in animal peroxisomes","volume":"32","author":"Hayashi","year":"2000","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.ejphar.2021.174291_bib28","first-page":"403","article-title":"Inhibiting URAT1 gene expression and reducing blood uric acid level of Chinese Traditional Medicine such as smilax glabra","volume":"17","author":"Hong","year":"2012","journal-title":"Chin. J. Clin. Pharmacol. Therapeut."},{"key":"10.1016\/j.ejphar.2021.174291_bib29","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jphs.2017.11.011","article-title":"The uricosuric effects of dihydropyridine calcium channel blockers in vivo using urate under-excretion animal models","volume":"136","author":"Hori","year":"2018","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2021.174291_bib30","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s10157-020-01849-0","article-title":"Dotinurad versus benzbromarone in Japanese hyperuricemic patient with or without gout: a randomized, double-blind, parallel-group, phase 3 study","volume":"24","author":"Hosoya","year":"2020","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.ejphar.2021.174291_bib31","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s40265-016-0550-y","article-title":"Lesinurad: first global approval","volume":"76","author":"Hoy","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2021.174291_bib32","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.biopha.2016.12.002","article-title":"(E)-2-(4-bromophenyl)-1-(2, 4-dihydroxyphenyl)ethanone oxime is a potential therapeutic agent for treatment of hyperuricemia through its dual inhibitory effects on XOD and URAT1","volume":"86","author":"Hu","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2021.174291_bib33","doi-asserted-by":"crossref","first-page":"8976","DOI":"10.3390\/molecules18088976","article-title":"Fructus Gardenia Extract ameliorates oxonate-induced hyperuricemia with renal dysfunction in mice by regulating organic ion transporters and mOIT3","volume":"18","author":"Hu","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2021.174291_bib34","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11926-016-0587-7","article-title":"Urate handling in the human body","volume":"18","author":"Hyndman","year":"2016","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.ejphar.2021.174291_bib35","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1124\/jpet.106.112755","article-title":"Concentration-dependent mode of interaction of angiotensin II receptor blockers with uric acid transporter","volume":"320","author":"Iwanaga","year":"2007","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2021.174291_bib36","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s12906-017-1834-9","article-title":"Caffeoylquinic acid derivatives rich extract from Gnaphalium pensylvanicum willd. Ameliorates hyperuricemia and acute gouty arthritis in animal model","volume":"17","author":"Jiang","year":"2017","journal-title":"BMC Compl. Alternative Med."},{"key":"10.1016\/j.ejphar.2021.174291_bib37","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.2147\/DDDT.S97959","article-title":"Guideline development for the management of gout: role of combination therapy with a focus on lesinurad","volume":"11","author":"Jones","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejphar.2021.174291_bib38","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/jcph.1119","article-title":"Pharmacokinetics, pharmacodynamics, and tolerability of concomitant multiple dose administration of Verinurad (RDEA3170) and allopurinol in adult male subjects with gout","volume":"58","author":"Kankam","year":"2018","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174291_bib39","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10157-019-01816-4","article-title":"Dotinurad: a clinical pharmacokinetic study of a novel, selective urate reabsorption inhibitor in subjects with hepatic impairment","volume":"24","author":"Kumagai","year":"2020","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.ejphar.2021.174291_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10157-019-01811-9","article-title":"Dotinurad: a novel selective urate reabsorption inhibitor as a future therapeutic option for hyperuricemia","volume":"24","author":"Kuriyama","year":"2019","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.ejphar.2021.174291_bib41","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/annrheumdis-2012-eular.2860","article-title":"Arhalofenate, a novel uricosuric agent, is an inhibitor of human uric acid transporters","volume":"71","author":"Lavan","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejphar.2021.174291_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201601030","article-title":"Negative correlation between serum uric acid and kidney URAT1 mRNA expression caused by resveratrol in rats","volume":"61","author":"Lee","year":"2017","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.ejphar.2021.174291_bib43","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1124\/dmd.119.087700","article-title":"Glucocorticoids increase renal excretion of urate in mice by downregulating urate transporter 1","volume":"47","author":"Li","year":"2019","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejphar.2021.174291_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19051394","article-title":"Hypouricemic effect of 2,5-dihydroxyacetophenone, a computational screened bioactive compound from ganoderma applanatum, on hyperuricemic mice","volume":"19","author":"Liang","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2021.174291_bib45","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11926-012-0240-z","article-title":"Regulation of uric acid excretion by the kidney","volume":"14","author":"Lipkowitz","year":"2012","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.ejphar.2021.174291_bib46","doi-asserted-by":"crossref","first-page":"7143","DOI":"10.1021\/acs.jafc.0c02535","article-title":"RDP3, A novel antigout peptide derived from water extract of rice","volume":"68","author":"Liu","year":"2020","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejphar.2021.174291_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.291","article-title":"Uricosuric targets of tranilast","volume":"5","author":"Mandal","year":"2017","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.ejphar.2021.174291_bib48","first-page":"F400","article-title":"Sodium-pyrazinoate cotransport in rabbit renal brush border membrane vesicles","volume":"249","author":"Manganel","year":"1985","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2021.174291_bib49","first-page":"446.1-446","article-title":"RDEA3170, a novel, high affinity URAT1 inhibitor binds to a central domain within URAT1","volume":"71","author":"Miner","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejphar.2021.174291_bib50","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s13075-016-1107-x","article-title":"Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney","volume":"18","author":"Miner","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ejphar.2021.174291_bib51","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1254\/jphs.10064SC","article-title":"Concentration-dependent inhibitory effect of irbesartan on renal uric acid transporters","volume":"114","author":"Nakamura","year":"2010","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2021.174291_bib52","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s10157-019-01836-0","article-title":"Clinical pharmacological study of dotinurad administered to male and female elderly or young subjects","volume":"24","author":"Nakatani","year":"2020","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.ejphar.2021.174291_bib53","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1002\/art.39687","article-title":"Editorial: pursuit of a dual-benefit antigout drug: a first look at arhalofenate","volume":"68","author":"Neogi","year":"2016","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2021.174291_bib54","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.12659\/MSM.903217","article-title":"Gypenosides inhibits Xanthine oxidoreductase and ameliorates urate excretion in hyperuricemic rats induced by high cholesterol and high fat food (lipid emulsion)","volume":"23","author":"Pang","year":"2017","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.ejphar.2021.174291_bib55","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.bmcl.2015.12.040","article-title":"Discovery of potent and orally bioavailable inhibitors of Human Uric Acid Transporter 1 (hURAT1) and binding mode prediction using homology model","volume":"26","author":"Peng","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejphar.2021.174291_bib56","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1039\/C6MD00191B","article-title":"The design, synthesis and evaluation of low molecular weight acidic sulfonamides as URAT1 inhibitors for the treatment of gout","volume":"7","author":"Pike","year":"2016","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejphar.2021.174291_bib57","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1002\/art.39684","article-title":"A randomized, double-blind, active- and placebo-controlled efficacy and safety study of arhalofenate for reducing flare in patients with gout","volume":"68","author":"Poiley","year":"2016","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2021.174291_bib58","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.apsb.2017.05.004","article-title":"Antihyperuricemic effect of mangiferin aglycon derivative J99745 by inhibiting xanthine oxidase activity and urate transporter 1 expression in mice","volume":"8","author":"Qin","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejphar.2021.174291_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12012-011-9145-8","article-title":"The history and future of probenecid","volume":"12","author":"Robbins","year":"2012","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.ejphar.2021.174291_bib60","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0022-3565(24)36490-0","article-title":"Effects of uricosuric and antiuricosuric agents on urate transport in human brush-border membrane vesicles","volume":"280","author":"Roch-Ramel","year":"1997","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2021.174291_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/nu12061601","article-title":"Omega-3 polyunsaturated fatty acids inhibit the function of human URAT1, a renal urate Re-absorber","volume":"12","author":"Saito","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.ejphar.2021.174291_bib62","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1517\/13543784.2015.1051617","article-title":"Investigational drugs for hyperuricemia","volume":"24","author":"Shahid","year":"2015","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.ejphar.2021.174291_bib63","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.2147\/DDDT.S140658","article-title":"Pharmacokinetics, pharmacodynamics, and tolerability of verinurad, a selective uric acid reabsorption inhibitor, in healthy adult male subjects","volume":"11","author":"Shen","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejphar.2021.174291_bib64","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/mnfr.201100828","article-title":"Antihyperuricemic and nephroprotective effects of resveratrol and its analogues in hyperuricemic mice","volume":"56","author":"Shi","year":"2012","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.ejphar.2021.174291_bib65","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s40261-018-0652-2","article-title":"Effect of renal impairment on the pharmacokinetics and pharmacodynamics of Verinurad, a selective uric acid reabsorption inhibitor","volume":"38","author":"Smith","year":"2018","journal-title":"Clin. Drug Invest."},{"key":"10.1016\/j.ejphar.2021.174291_bib66","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1172\/JCI42344","article-title":"Uric acid transport and disease","volume":"120","author":"So","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2021.174291_bib67","doi-asserted-by":"crossref","first-page":"9512","DOI":"10.1038\/s41598-020-66205-4","article-title":"Molecular and histopathological study on the ameliorative impacts of petroselinum crispum and Apium graveolens against experimental hyperuricemia","volume":"10","author":"Soliman","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2021.174291_bib68","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3899\/jrheum.161062","article-title":"The pharmacodynamics, pharmacokinetics, and safety of arhalofenate in combination with febuxostat when treating hyperuricemia associated with gout","volume":"44","author":"Steinberg","year":"2017","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.ejphar.2021.174291_bib69","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3899\/jrheum.101160","article-title":"Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in patients with gout","volume":"38","author":"Stocker","year":"2011","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.ejphar.2021.174291_bib70","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1039\/C6MD00190D","article-title":"The discovery and evaluation of diaryl ether heterocyclic sulfonamides as URAT1 inhibitors for the treatment of gout","volume":"7","author":"Storer","year":"2016","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejphar.2021.174291_bib71","doi-asserted-by":"crossref","first-page":"5817348","DOI":"10.1155\/2020\/5817348","article-title":"Research advances in the mechanisms of hyperuricemia-induced renal injury","volume":"2020","author":"Su","year":"2020","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ejphar.2021.174291_bib72","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1007\/s12272-014-0413-6","article-title":"Anti-hyperuricemic and nephroprotective effects of Rhizoma Dioscoreae septemlobae extracts and its main component dioscin via regulation of mOAT1, mURAT1 and mOCT2 in hypertensive mice","volume":"37","author":"Su","year":"2014","journal-title":"Arch Pharm. Res."},{"key":"10.1016\/j.ejphar.2021.174291_bib73","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000487675","article-title":"Hypouricemic and nephroprotective effects of an active fraction from polyrhachis Vicina Roger on potassium oxonate-induced hyperuricemia in rats","volume":"43","author":"Su","year":"2018","journal-title":"Kidney Blood Press. Res."},{"key":"10.1016\/j.ejphar.2021.174291_bib74","doi-asserted-by":"crossref","first-page":"34995","DOI":"10.1038\/srep34995","article-title":"Mechanism of high affinity inhibition of the human urate transporter URAT1","volume":"6","author":"Tan","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2021.174291_bib75","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41598-017-00706-7","article-title":"Discovery and characterization of verinurad, a potent and specific inhibitor of URAT1 for the treatment of hyperuricemia and gout","volume":"7","author":"Tan","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2021.174291_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23112837","article-title":"Effects of osthol isolated from cnidium monnieri fruit on urate transporter 1","volume":"23","author":"Tashiro","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2021.174291_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028641","article-title":"Clinical and functional characterization of URAT1 variants","volume":"6","author":"Tasic","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2021.174291_bib78","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21111543","article-title":"Discovery of a flexible triazolylbutanoic acid as a highly potent uric acid transporter 1 (URAT1) inhibitor","volume":"21","author":"Tian","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2021.174291_bib79","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41538-020-0063-7","article-title":"Inhibitory effect of Citrus flavonoids on the in vitro transport activity of human urate transporter 1 (URAT1\/SLC22A12), a renal re-absorber of urate","volume":"4","author":"Toyoda","year":"2020","journal-title":"NPJ Sci Food"},{"key":"10.1016\/j.ejphar.2021.174291_bib80","doi-asserted-by":"crossref","DOI":"10.1021\/acsmedchemlett.0c00176","article-title":"Discovery of dotinurad (FYU-981), a new phenol derivative with highly potent uric acid lowering activity","author":"Uda","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2021.174291_bib81","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2169\/internalmedicine.49.2597","article-title":"Effect of fenofibrate on uric acid metabolism and urate transporter 1","volume":"49","author":"Uetake","year":"2010","journal-title":"Intern. Med."},{"key":"10.1016\/j.ejphar.2021.174291_bib82","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1136\/bmj.332.7553.1315","article-title":"Diagnosis and management of gout","volume":"332","author":"Underwood","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.ejphar.2021.174291_bib83","article-title":"Probable potential role of urate transporter genes in the development of metabolic disorders","volume":"10","author":"Vadakedath","year":"2018","journal-title":"Cureus"},{"key":"10.1016\/j.ejphar.2021.174291_bib84","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1021\/acsmedchemlett.6b00465","article-title":"Discovery and assessment of atropisomers of (+\/-)-Lesinurad","volume":"8","author":"Wang","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2021.174291_bib85","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1021\/jm1015022","article-title":"Developing potent human uric acid transporter 1 (hURAT1) inhibitors","volume":"54","author":"Wempe","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2021.174291_bib86","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.carbpol.2011.12.029","article-title":"Biological activities and potential industrial applications of fucose rich sulfated polysaccharides and fucoidans isolated from brown seaweeds: a review","volume":"88","author":"Wijesinghe","year":"2012","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejphar.2021.174291_bib87","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1177\/2040622315596119","article-title":"The effect of angiotensin II receptor blockers on hyperuricemia","volume":"6","author":"Wolff","year":"2015","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.ejphar.2021.174291_bib88","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.bmcl.2018.12.036","article-title":"Synthesis, biological evaluation and 3D-QSAR studies of 1,2,4-triazole-5-substituted carboxylic acid bioisosteres as uric acid transporter 1 (URAT1) inhibitors for the treatment of hyperuricemia associated with gout","volume":"29","author":"Wu","year":"2019","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejphar.2021.174291_bib89","doi-asserted-by":"crossref","first-page":"3458185","DOI":"10.1155\/2018\/3458185","article-title":"Study of the treatment effects of compound tufuling granules in hyperuricemic rats using serum metabolomics","author":"Wu","year":"2018","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.ejphar.2021.174291_bib90","doi-asserted-by":"crossref","first-page":"100852","DOI":"10.18632\/oncotarget.20135","article-title":"Recent advances on uric acid transporters","volume":"8","author":"Xu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2021.174291_bib91","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jep.2013.09.024","article-title":"Study on the correlation between constituents detected in serum from Rhizoma Smilacis Glabrae and the reduction of uric acid levels in hyperuricemia","volume":"150","author":"Xu","year":"2013","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejphar.2021.174291_bib92","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3389\/fmicb.2018.00058","article-title":"Cordycepin, a characteristic bioactive constituent in cordyceps militaris, ameliorates hyperuricemia through URAT1 in hyperuricemic mice","volume":"9","author":"Yong","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejphar.2021.174291_bib93","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1172\/JCI103905","article-title":"Study of the paradoxical effects of salicylate in low, intermediate and high dosage on the renal mechanisms for excretion of urate in man","volume":"38","author":"Yu","year":"1959","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2021.174291_bib94","doi-asserted-by":"crossref","DOI":"10.3390\/md16120472","article-title":"Production inhibition and excretion promotion of urate by fucoidan from Laminaria japonica in adenine-induced hyperuricemic mice","volume":"16","author":"Zhang","year":"2018","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejphar.2021.174291_bib95","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/annrheumdis-2012-202589","article-title":"Low-dose aspirin use and recurrent gout attacks","volume":"73","author":"Zhang","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejphar.2021.174291_bib96","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jep.2017.12.004","article-title":"Effect and mechanism of dioscin from Dioscorea spongiosa on uric acid excretion in animal model of hyperuricemia","volume":"214","author":"Zhang","year":"2018","journal-title":"J. Ethnopharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921004441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921004441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:13:42Z","timestamp":1762143222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299921004441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":96,"alternative-id":["S0014299921004441"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174291","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A brief review of urate transporter 1 (URAT1) inhibitors for the treatment of hyperuricemia and gout: Current therapeutic options and potential applications","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174291","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"174291"}}